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Abstract
Background: Frailty is common in many patients with advanced heart failure, including those who
undergo left ventricular assist device (LVAD) implantation. Frailty has been associated with worse
outcomes after other cardiac surgeries; however, little is known about the effect of frailty on
postoperative outcomes after LVAD implant.
Purpose: The purpose of this project was to evaluate whether preoperative frailty [as determined by
either short physical performance battery (SPPB) score ≤ 7/12 or 6-minute walk test (6-MWT) <200
meters] is associated with poorer postoperative outcomes after LVAD implantation than non-frailty
in adults with advanced heart failure.
Setting and Sample: This project was conducted at UK Chandler Hospital, a 945-bed, academic
medical center. 120 adult advanced heart failure patients who had an LVAD implanted at UK
Chandler Hospital between May 2015 and April 2020 were included in the sample.
Design: This project was a descriptive study employing retrospective and prospective chart review.
Methods: Data was collected through chart review from LVAD patients with documented
preoperative 6-MWT and SPPB scores. Patients were considered frail if they had a 6-MWT <200 m
or SPPB score ≤ 7/12. Postoperative outcomes of hospital and ICU length of stay (LOS), time
mechanically ventilated, placement of tracheostomy, discharge disposition, inpatient and one-year
mortality, hospital readmissions at 30 and 90 days, and change in pre- and postoperative quality of
life scores (QOL) were compared between frail and non-frail patients. Demographic and health data
were collected and compared between frail and non-frail groups. Data was analyzed using SPSS
software with the guidance of a university statistician.
Results: 41.1% of patients (n=46) had a SPPB score ≤ 7/12 and 53.3% of patients (n=64) had 6MWT < 200 meters. When SPPB ≤ 7/12 was used to determine, frailty was associated with increased
1- year mortality (33.3 vs 15.6%, p=0.030), length of stay (LOS) (31 vs 18.5 days, p<0.001), ICU
LOS (15 vs 9.5 days, p<0.001) time mechanically ventilated (81 vs 22.75 h, p <0.001), tracheostomy
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placement (31.1% vs 4.6%, p<0.001), and discharge to inpatient facility rather than home (55.0% vs
16.7%, p <0.001). When 6-MWT < 200m was used to determine frailty, frailty was associated with
increased 1-year mortality (31.3 vs 13.2%, p=0.021), LOS (24 vs 19 days, p=0.021), time
mechanically ventilated (71.25 vs 22.0 h, p <0.001), tracheostomy placement (23.8% vs 5.5%,
p=0.006), and discharge to inpatient facility rather than home (47.4% vs 11.8%, p <0.001). ICU LOS
was also longer (13 vs 10 days) for frail patients according to this measure but did not reach
statistical significance (p=0.059). After adjusting for age, gender, BMI and other comorbidities,
frailty defined by SPPB ≤ 7/12 was a significant predictor of increased ICU and hospital LOS, time
mechanically ventilated, tracheostomy placement and discharge to inpatient facility, whereas 6MWT < 200m was not a significant predictor in logistic regression models. No significant difference
was found in inpatient mortality, 30 and 90-day readmission rates, or change in pre-and postoperative
QOL scores for either frailty indicator.
Conclusion: Preoperative frailty is associated with worse postoperative outcomes, particularly,
increased 1-year mortality, hospital and ICU LOS, time mechanically ventilated, tracheostomy
placement, and discharge to an inpatient facility other than home after LVAD implant. Preoperative
frailty assessment, should therefore, be completed on all patients prior to implantation, as the results
can be used to help identify which patients may be less likely to benefit from this therapy or who
may require more resources postoperatively. Based on this study’s analysis, SPPB is likely a better
measure of frailty than 6-MWT in predicting negative outcomes.
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Relationship between Preoperative Frailty & Postoperative Outcomes after LVAD
Implantation
Background and Significance
Introduction/ Problem Identification
Frailty, which is characterized by increased physiological vulnerability, reduced resilience to
stressors, and progressive loss of physiological function (Tse et al., 2018), is common in many
patients with advanced heart failure, including those who undergo left ventricular assist device
(LVAD) surgical implantation. Frailty has been shown to worsen patient outcomes after other types
of invasive cardiac procedures and surgery (Bergquist et al., 2018); however, little is known about
the effect of frailty on postoperative outcomes after LVAD implant, as few studies have been
conducted examining the extent to which frailty increases the likelihood of adverse outcomes in this
population.
Context, Scope, and Consequences of the Problem
Frailty has an estimated prevalence of 28% among adult patients with advanced heart failure
(Joyce, 2016). Patients with heart failure and left ventricular dysfunction requiring LVAD
implantation often have reduced exercise tolerance, cachexia, and a variety of comorbidities which
may increase their risk for frailty. In fact, approximately 60% of patients undergoing LVAD
implantation patient were found to be frail preoperatively (Joyce, 2016). Frailty may put patients at
increased risk for complications post-implant. Large multicenter research studies and systematic
reviews have demonstrated an association between frailty and worse postoperative outcomes
including increased mortality and length of stay, prolonged mechanical ventilation, and
complications such as bleeding and renal failure after other cardiac surgeries such as coronary artery
bypass surgery or mitral and atrial valve surgeries (Abdullahi et al., 2017; Bäck et al. 2019; &
Bergquist et al., 2018). As LVAD implantation, however, is designed to increase cardiac output and
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reverse symptoms of heart failure, it is unclear if preoperative frailty will influence postoperative
outcomes in the same manner as in other cardiac surgeries.
Currently, however, few studies have specifically assessed the effect of preoperative frailty
on postoperative outcomes after LVAD implantation. Preliminary studies have demonstrated worse
outcomes for frail patients after LVAD surgery, including increased time to extubation, hospital
length of stay, and long-term mortality (Joseph et al., 2016; Tse et al., 2018). Most of these studies
assessed frailty using Fried scores or hand grip strength. At University of Kentucky (UK) Healthcare,
however, frailty is assessed using different tools: SPPB and 6-MWT. Although both the SPPB and 6MWT are validated tools frequently used to assess frailty in patients with advanced heart failure
(Llopis et al., 2019 & Pandey et al., 2019), these particular tools have been minimally used in studies
evaluating the effect of pre-operative frailty on post-operative outcomes after LVAD implantation.
There was a need for additional research examining the effect of preoperative frailty on postoperative
outcomes after LVAD implantation, specifically using 6-MWT and SPPB to assess frailty.
Purpose & Objectives
Therefore, a retrospective chart review was conducted to assess whether preoperative frailty
(as determined by either SPPB ≤ 7/12 or 6-MWT <200 meters) is associated with poorer
postoperative outcomes after LVAD implantation in adult patient with advanced heart failure.
Primary project objectives were to:
1) Assess whether preoperative frailty as measured by 6-MWT <200 meters is associated with the
following poorer postoperative outcomes than non-frailty: 1) increased inpatient and one-year
mortality, 2) increased hospital and ICU LOS, 3) increased time on mechanical ventilation, 4)
increased frequency of tracheostomy placement, 5) less discharges home, 6) increased hospital
readmissions at 30 and 90 days after discharge, and 7) less improvement between pre- and
postoperative in QOL scores
2) Assess whether preoperative frailty as measured SPPB score ≤ 7/12 meters is associated with
the following poorer postoperative outcomes than non-frailty: 1) increased inpatient and oneyear mortality, 2) increased hospital and ICU LOS, 3) increased time on mechanical ventilation,
4) increased frequency of tracheostomy placement, 5) less discharges home, 6) increased
hospital readmissions at 30 and 90 days after discharge, and 7) less improvement between preand postoperative in QOL scores
7

Additional project objectives were to:
1) Describe population sample using the following demographic and health data: Gender, race, age,
Ejection fraction, New York Heart Failure (NYHF) Class/ American Heart Association (AHA)
stage, BMI, Interagency Registry for Mechanically Assisted Circulatory Support
(INTERMACS) profile score, cardiac index, presence of comorbid conditions (DM, HTN,
CKD, COPD, RV dysfunction, & pulmonary hypertension), type of LVAD implanted,
ischemic/non-ischemic cardiomyopathy, presence of prior sternotomy
2) Determine whether any demographic or health variables differ significantly between frail and
non-frail groups
3) Determine if 6-MWT <200 meters or SPPB score ≤ 7/12 if a stronger predictor of negative
postoperative outcomes
4) Determine whether demographic or health-related variable were more significant predictors of
negative postoperative outcomes than pre-operative frailty
5) Compare patients’ pre- and postoperative 6-MWTs and determine whether postoperative 6MWT was a more significant predictor of negative outcomes than preoperative 6-MWT
Theoretical Framework
The theoretical framework selected to guide this project was The Iowa Model of Evidence
Based Practice to Promote Quality Care, which was developed by Marita Titler and her colleagues
(2001) at the University of Iowa and revised in 2017 by the Iowa Model Collaborative (Buckwalter
et al., 2017. Appendix A). The Iowa Model outlines a multistep framework that nurses and clinicians
can use to implement evidence-based practice (EBP). Under this model, clinicians identify a
triggering issue that might warrant practice change, develop a related clinical question or project
purpose, determine if the issue is a truly a priority at their institution, and assemble a team to review
literature and gather data concerning the project/ question. At this point, the team must determine
whether there is sufficient evidence to warrant a practice change. If there is not, the Iowa Model
suggests that the team consider conducting additional research. Once evidence is sufficient to warrant
change, the team then designs, pilots, and evaluates a practice change. If deemed appropriate, this
change is adopted into long-term practice and results of the EBP change are disseminated to others.
In line with the Iowa Model, a triggering issue—the potential for adverse outcomes postLVAD implantation due to preoperative frailty—was identified. This issue is of value at UK
Healthcare, as patient outcomes measures are closely tracked after LVAD placement to improve
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upon care. Current evidence on the effect of preoperative frailty on postoperative outcomes after
LVAD implantation is currently too limited to necessitate a practice change. Therefore, in line with
the Iowa Model, this research project was designed and executed to further investigate the effect of
preoperative frailty on postoperative outcomes in LVAD recipients. The results of this research will
be added to the current body of evidence concerning this triggering issue and may be used to assess
the need for practice change.
Review and Synthesis of the Evidence in the Literature
Search Methods
In line with the Iowa Model (Titler, 2001), a literature review was conducted to evaluate
current evidence on the effect of preoperative frailty on postoperative outcomes after LVAD
implantation. For this literature search, the electronic databases CINAHL, PubMed, and Academic
Search Complete were searched for studies that evaluated the relationship between preoperative
frailty and patient outcomes after LVAD implantation. The key word search terms used were frailty
AND left ventricular assist device OR heart assist device. Criteria for inclusion were that the article
be in English, from the year 2010 or later, and study adults. Articles were excluded if they were not
original research studies, did not evaluate patients who underwent LVAD implantation, or did not
quantify preoperative frailty using a tool and then relate this measure to post-implantation outcomes.
This search strategy yielded 66 references that met inclusion criteria. Of these, 56 were excluded due
to duplication or pre-determined exclusion criteria, leaving 10 articles for inclusion.
Synthesis of Evidence
Of the 10 studies included, three were retrospective chart reviews (Cooper et al., 2017;
Herberton et al., 2016; & Jha et al., 2017); the remaining seven were prospective observational
studies. The majority (6/10) used a Fried score of 3/5 or greater to determine frailty (Jha, et al., 2017;
Joseph et al., 2017; Manghelli, et al., 2014; Reeves et al., 2016; Stein et al., 2019; & Uzun et al.,
2019). Frailty was determined by handgrip strength in two studies (Chung et al., 2014 & Stein et al.,
9

2019) and by the following measures in one study: frailty deficit index (Dunlay et al., 2014), low
psoas muscle mass (Herberton et al., 2016), and gait speed <0.8m/sec or by provider survey (Cooper
et al., 2017). Outcomes assessed in these studies included mortality, length of stay, readmission rates,
time mechanically ventilated, and several outcomes unique to individual studies. A syntheses table
summarizing this literature review is included in Table 1.
Of the six studies which assessed long-term mortality, five found preoperative frailty to be
associated with statistically higher mortality at 6 months and 1 year. Four of these studies (Chung et
al. 2014; Cooper et al., 2017; Dunlay et al., 2014; Stein et al., 2019) reached statistical significance,
while one did not (Jha et al., 2017). The last study found no difference between frail and non-frail
patients (Joseph et al., 2017). The influence of frailty on short-term mortality in the postoperative
inpatient period was assessed in 5 studies, all of which found that frailty was associated with
increased inpatient mortality; however, none of these results reached statistical significance (Cooper
et al., 2017; Herberton et al., 2016; Joseph et al., 2017; Manghelli et al., 2014; & Uzun et al., 2019).
Nine studies assessed the effect of frailty on postoperative length of stay (LOS), the majority
of which (7/9) found that patients who were frail preoperatively had longer LOS. The results of 3 of
these studies (Jha et al., 2017; Josesph et al., 2017; & Stein et al., 2019) reached statistical
significance; however, 4 studies did not (Herberton et al., 2016; Manghelli et al., 2014; Reeves et al.,
2016; & Uzun et al., 2019). Two studies, on the other hand, found that postoperative LOS did not
differ significantly between frail and non-frail patients (Cooper et al., 2017 & Dunlay et. al, 2014).
Time mechanically ventilated postoperatively was also compared in three studies, all of
which found that found that patients who were frail spent 24-68 hours longer on the ventilator than
non-frail patients after LVAD implantation Two of these studies reached statistical significance
(Joseph et al., 2017 & Mangelli et al., 2014), while the third did not (Jha et al., 2017).
Two studies assessed rehospitalization rates post- LVAD implantation and found
readmission rates to be similar between frail and non-frail patients (Cooper et al., 2017 & Dunlay et
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al., 2014). Preoperative frailty was associated with significantly worse post-operative depression and
quality of life (QOL) scores (Reeves et al., 2016), and increased (although not statistically
significant) likelihood of discharge to rehab facility rather than home (Dunlay et. al., 2016).
Summary of Literature Review Findings and Gap in Evidence
Overall, the results of these studies demonstrate a clinically significant trend toward worse
outcomes post-LVAD implantation for patients who were frail preoperatively, including increased
inpatient and long-term mortality, length of stay, and time on ventilator; however, while some studies
report significant results, many findings were not statistically significant, and two studies found no
difference in long-term mortality and LOS (See Table 1). Frail patients did have significantly worse
post-operative QOL and depression scores; however, these variables were assessed in only one study.
Readmission rates were found to be similar between frail and non-frail patients in both studies
assessing this outcome. Despite some variance in findings, it should be noted that no study reported
better outcomes—and most demonstrate worse outcomes—for patients who are frail preoperatively
than their non-frail counterparts.
Overall, relatively few studies—ten—evaluated the association between preoperative frailty
and outcomes after LVAD implantation. Most studies (6/10) used Fried scores to determine frailty.
All other metrics were utilized in two studies or less. No studies in this review employed use of the
short SPPB to determine frailty and only one study used gait speed although these tools have been
used reliably to assess frailty in patients advanced heart failure (Llopis et al., 2019 & Pandey et al.,
2019). Outcomes such as ventilator time and readmission rates were evaluated in three or fewer
studies, and postoperative QOL, depression, and discharge disposition were only assessed in one
study each. And, while most studies assessed the influence of frailty on postoperative mortality and
LOS, many of these studies failed to reach statistical significance (Cooper et al., 2016, Herberton et
al., 2016, Jha et al., 2017, Joseph et al., 2017, Mangelli et al., 2014, Uzam et al, 2019).
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While studies were of a moderate level of evidence (all were observational, non-experimental
prospective or retrospective research studies), the overall strength of the evidence is relatively weak,
as most studies had small sample sizes and many findings were not statistically significant. All but
one of the studies (Cooper et al., 2017) were single center studies with small sample sizes of 44-100
patients; therefore, their results may be underpowered and lack generalizability. Unfortunately, the
one study which was a multi-center study with a large sample size (Cooper et al., 2017) utilized a
relatively subjective provider assessment of frailty and reported that there were gaps in the database
from which information was gathered, which may put the study at risk for inaccuracies or bias.
There is a need for additional research concerning the effect of preoperative frailty on
postoperative outcomes LVAD implantation. Additional research is needed to evaluate each of the
outcomes discussed above in this review, especially quality of life, discharge disposition, and ICU
LOS which were addressed by only one or two studies. Research evaluating preoperative frailty
using measures which have not yet been studied with LVAD implantation—specifically SPPB,
which is the tool we use at UK Hospital, or minimally studied (such as gait speed; i.e. the 6-MWT) is
also needed. These are the gaps in current research this project aimed to address.
Methods
Design
This project was a descriptive research study with retrospective and prospective chart review
designed to assess the relationship between preoperative frailty and postoperative outcomes after
LVAD implantation. This study included advanced heart failure patients who had an LVAD
implanted at UK Chandler Hospital between May 1, 2015 and April 30, 2020. Records from January
2015 to December 31, 2020 were accessed for this review.
Postoperative outcomes—hospital and ICU length of stay, postoperative time on ventilator,
tracheostomy placement, discharge disposition, inpatient and 1-year mortality, readmission at 30 and
90 days after discharge, and change in pre- and post-operative quality of life scores—were compared
12

between patients who were designated as frail or non-frail based on their previously documented 6MWT or SPPB score. Demographic data and preoperative health data were collected and compared
between the groups to determine if there is any significant difference between frail and non-frail
groups and to assess whether any of these variables has a more significant influence on postoperative
outcomes than preoperative frailty.
Setting
Agency Description. This project was conducted at the UK Chandler Hospital in Lexington,
Kentucky. UK Chandler Hospital is a large, 945-bed, academic medical center that includes the Gill
Heart Institute, a multidisciplinary team providing healthcare to patients with a wide range of
cardiovascular conditions, including those with advanced heart failure who have undergone LVAD
placement. Inpatient and outpatient care of LVAD patients is managed by the institution’s Advanced
Heart Failure team and a team of specially trained LVAD coordinators who coordinate pre-implant
workup, post-operative care, and long-term health management of patients with a LVAD.
Project Congruence with Organizational Mission and Goals. As a key decision point in
following the Iowa Model (Titler, 2001), concern for adverse outcomes after LVAD implantation as
a result of preoperative frailty was determined to be a priority at UK Healthcare. UK Healthcare’s
mission statement emphasizes the organization’s dedication to providing the most advanced care to
the people of Kentucky and its commitment to the pillars of academic healthcare: research,
education, and clinical care (UK HealthCare, n.d.). The organization is publicly committed to the
value of innovation, stating that they “embrace continual learning and improvement to drive positive
change” (UK HealthCare, n.d.). It is a goal of the Gill Heart Institute to excel in clinical outcomes in
cardiovascular health and disease by using quality outcomes and research data to drive continuous
improvements (UK HealthCare, 2015). In pursuit of this goal, the team of heart failure providers and
cardiovascular surgeons at UK Healthcare closely track and work to improve postoperative outcomes
after LVAD placement.
13

The aim of this project was to understand more about whether preoperative frailty negatively
influences postoperative outcomes after LVAD implantation and whether the SPPB and 6-MWT can
add significant prognostic information to aid in the selection of patients for LVAD implantation to
prevent harm and improve patient outcomes. This objective aligns with the goals and mission of UK
Healthcare and addresses the issue of potentially worse outcomes after LVAD implant because of
frailty, which is a priority at the institution.
Stakeholder Identification. Stakeholders influential to my project include the mechanical
circulatory support (MCS) team who coordinate care for LVAD patients, the physical therapists who
evaluate and work with patients before and after LVAD implantation, the heart failure providers who
care for LVAD patients, cardiothoracic surgeons who implant LVADs, and the patients with heart
failure who receive LVADs. The hospital’s MCS LVAD coordinators helped to provide information
concerning data collection pre- and post-LVAD implantation for this project. Several physical
therapists who evaluate patients pre- and post-implantation also took interest in this project and
provided detailed information concerning the process of frailty assessment at UK Hospital using 6MWT and SPPB score. At the completion of this project, results will be shared with these
stakeholders to address their potential influence on current practice.
Patients who undergo LVAD implantation at UK Hospital are this study’s target population,
and are, thus, also important stakeholders. Ultimately, the results of this project may influence the
selection and education of future patients concerning the risks and benefits of LVAD implantation
associated with their level of frailty.
Site-Specific Facilitators and Barriers to Implementation. There are several site-specific
factors which helped to facilitate implementation of my project. As described above, this project
aligned with UK Healthcare’s mission and goals of conducting outcomes research in order to
promote best practice and improved patient outcomes. Additionally, the MCS manager and
coordinators and physical therapists were willing to offer expertise and help facilitate data collection.
14

As the design of this project was a chart review, it did not require a large amount of space, personnel,
or financial resources to implement.
In addition to these facilitators, there were also several factors which served as barriers to
data collection. 6-MWT and SPPB scores are documented in inconsistent locations within the EMR
and were not documented on every patient postoperatively. There is also no efficient, accurate way to
assess time mechanically ventilated or LOS after LVAD implantation surgery; therefore, each of
these outcomes had to be manually audited. Pre- and postoperative QOL scores were documented on
paper charts, and, although every patient is supposed to have these assessments documented preimplantation and at 6 months and 1 year after discharge, the majority were missing this
documentation. Post-operative 6-MWT were also documented at inconsistent points in time
postoperatively. These barriers made data retrieval more time consuming and resulted in missing data
for some outcomes.
Sample
The sample for my study included 120 adult patients with advanced heart failure who had a
LVAD implanted at UK Chandler Hospital between May 1, 2015 and April 30, 2020. This sample
includes adult patients of varying age, gender, race, socio-economic and education backgrounds from
the state of Kentucky as well as multiple surrounding states.
Patients were identified for inclusion to this study through chart review. Criteria for inclusion
were that patients: 1) had undergone LVAD implantation at University of Kentucky Hospital
between May 1, 2015 and April 30, 2020, and 2) had documentation of preoperative 6-MWT and/or
SPPB score or documentation indicating inability to complete these assessments due to frailty or
medical condition. Patients were excluded if they had no documentation discussing preoperative
frailty assessments. Of the 129 patients who were identified for inclusion, 9 were excluded based on
predetermined criteria, leaving 120 patients to be included in the final sample.
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Procedure
IRB Approval. Prior to initiation of data collection, approval was obtained from the
University of Kentucky Institutional Review Board to conduct this project through exemption
certification.
Measures and instruments. Preoperative frailty was determined using documented
preoperative 6-MWT and SPPB scores. The assessments documented most recently before LVAD
implantation, and no more than 6 months prior to implantation, were utilized in this study.
A 6-MWT is measured by timing the distance a patient walks in 6 minutes in an unobstructed
hallway or around a track. The 6-MWT is a widely used measure to assess physical performance in
patients with heart failure (Yamamoto et. al, 2020) and has been used reliably to determine frailty in
patients with heart failure (intra-class co-efficient of 0.9; p<0.0001) (Uszko-Lenscer, 2017).
Established guidelines for conducting 6-MWTs have been released by the American Thoracic
Society to help providers reliably reproduce the assessment (Holland et al., 2014). 6-MWT has also
been determined to be valid tool to assess frailty in patients with heart failure. Progressive decline in
distance walked during the 6-MWT is associated with progressive decline in peak aerobic capacity
and progressive decline in other measures of physical performance like Fried scores and shuttle
walks (Boxer et al., 2010, Giannitsi, 2019). Shorter distances walked are also associated with worse
clinical outcomes such as increased mortality for patients with heart failure (Giannitsi, 2019;
Yamamoto et. al, 2020).
Different distance cutoffs, usually ranging from 200-300 meters have been used to determine
frailty in patients with heart failure. Yamada and colleagues (2015), as well as Guazzi and colleagues
(2009), found a 6-MWT of <300 meters to be associated with a significantly higher risk of mortality
in patients with heart failure, while a cutoff of <200 meters or less predicted increased mortality in
other studies (Alahdab, 2009; Curtis et al., 2004). In a study conducted by Yap and colleagues
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(2015), the inability to walk a distance of 225 meters or more was found to be predictive of worse
clinical outcomes for patients in NYHF classes III and IV.
When evaluating my sample, 80.8% of patients walked less than 300 meters and 53.3%
walked less than 200 meters during their preoperative 6-MWT. In other research studies assessing the
effect of frailty on postoperative outcomes after LVAD implantation, frailty prevalence ranged from
22.2 % to 75% (Chung et al., 2014; Reeves et al., 2016). A 6-MWT of <200 meters was, therefore,
used to define frailty in this study, as the sample’s prevalence of frailty using this cutoff better
correlated with the prevalence of frailty in other studies, and 200 meters has been previously used to
define frailty in patients with advanced heart failure. As many patients undergoing LVAD implant
are typically in NYHF classes III-IV, a 6-MWT less than 200 meters may more closely predict
negative outcomes in this population as well.
The SPPB test consists of 3 components: standing balance, gait speed, and timed repeated
chair rises. Each of the components is scored on a scale of 0 to 4 and combined for a total score
ranging for 0 to 12, with a lower score indicating greater functional impairment. A copy of the SPPB
assessment is provided in Appendix B. The SPPB score is a well-established tool that provides
reproducible measurement of physical function in older adults and has been used to determine frailty
in patients with heart failure (Pandey et al., 2019; Chiarantini et. al, 2010). A score of less than 8 has
been found to best predict frailty with sensitivity (79.9%) and specificity (73.8%) (Perracini et. al,
2020) and to be associated with low grip strength (OR 2.45, p<0.05) and falls (OR 1.49, p <0.05)(
(Ramírez-Vélez, 2020). In this study, therefore, patients were, considered frail if they had a score less
than or equal to 7 of 12.
The postoperative outcomes assessed in this study were inpatient and one-year mortality,
hospital LOS and ICU LOS, time mechanically ventilated, tracheostomy placement, discharge
disposition, hospital readmissions at 30 and 90 days, and change in pre- and post-operative QOL
scores. Inpatient mortality and 1-year mortality were determined by presence of a documented date
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of death during initial postoperative hospitalization or within the first year after LVAD implantation.
Post-operative tracheostomy placement was determined by presence of documented tracheostomy
operative note. For patients who survived to discharge, LOS and ICU LOS were measured in days.
Postoperative time on mechanical ventilation was measured in cumulative hours of documented time
mechanically ventilated. Hospital readmissions at 30 and 90 days were determined by presence of
admission H&P documented within 30 or 90 days after postoperative hospitalization discharge date.
Change in pre- and postoperative quality of life scores were measured using the difference
between pre- and postoperative 3-level EuroQol 5 Dimensions Questionnaire (EQ-5D-3L) scores and
12-item Kansas City Cardiomyopathy questionnaire (KCCQ-12) scores. The EQ-5D-3L is a selfcompleted patient questionnaire assessing 5 dimensions: mobility, self-care, usual activities, pain/
discomfort and anxiety/depression and has been found to assess quality of life reliably for patient
with cardiac conditions and after cardiac surgery (Schweikert, Hahmann, & Leidl, 2006; Heiskanen
et al., 2016). Maximum score is 25 points, with higher scores indicating higher reported QOL. The
KCCQ-12 is a 12-item self-completed patient questionnaire and is a validated tool for assessing
quality of life in patients with heart failure (Spertus & Jones, 2015). Maximum score is 64 points,
with higher scores indicating higher reported QOL.
Other demographic and baseline health data, including age, gender, race, heart failure
classification, and comorbidities as well as postoperative 6-MWT (which was measured as described
above and documented within the first postoperative year), were collected to compare frail and nonfrail groups and to assess confounding variables. A table listing study variables and their measures is
included in Appendix C.
Data Collection. Study personnel obtained a list of medical record numbers for patients who
had undergone LVAD implantation at UK Chandler Hospital between May 1, 2015 and April 30,
2020 from UK Healthcare’s LVAD coordinating team. This list was used to conduct a chart review
of retrospective and prospective data from patients’ electronic and paper medical records.
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Records from January 2015 to December 31, 2020 were accessed for this review. Data
prospectively collected included inpatient and one-year morality and postoperative EQ-5d-3L and
KCCQ-12 quality of life assessments documented as part of routine care provided within the data
collection period which lasted from September 1, 2020 to January 31, 2021. All other data was
retrospectively collected.
Data Analysis. Data analysis was conducted using IBM SPSS Statistics Version 26 software
with the guidance of a university statistician. Demographic and baseline health data, and frailty
prevalence were analyzed using descriptive statistics. Bivariate statistics including Chi-Square and
Fischer’s exact tests, independent samples t tests, and Mann-Whitney tests were used to assess the
association between each measure of frailty and postoperative outcomes and to compare
demographic and health characteristic data between frail and non-frail groups. McNemar test was
used to compare patients’ preoperative 6-MWT with their post-implant performance.
Logistic regression models were used to examine predictors of tracheotomy placement,
discharge disposition, one-year mortality, hospital and ICU LOS, and time mechanically ventilated.
Because the distributions for hospital LOS, vent hours and ICU LOS were right skewed, we created
binary (yes/no) variables for whether the patient experienced the outcome greater than the 75th
percentile. Cutoffs were LOS greater than 33 days, ICU LOS greater than 18 days, and greater than
101 hours mechanically ventilated. Each logistic regression model included the two measures of
frailty along with age, gender, BMI, previous sternotomy, preoperative reduction in RVEF, and
comorbid conditions (DM, COPD, HTN, PHTN).
Level of significance was set at P ≤ 0.05 for all analyses.
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Results
Frailty prevalence
120 of the 120 patients included had documented preoperative 6-MWTs. Overall mean
6MWT was 191.71 (± 110.7) meters. 53.3% of patients (n=64) had 6-MWT of 200 meters or less,
which identified them as frail for purposes of this study.
112 of the 120 patients had documented SPPB tests. Overall mean SPPB score was 7.55 (±
4.06). 41.1% of patients (n=46) had a SPPB score of 7/12 or less and were identified as frail for
purposes of this study.
Demographics and baseline health data
Overall mean age was 53.9 years (range 18-83). 84.2% of the overall sample were male;
90.0% were Caucasian. Mean cardiac index was 1.83 L/min/m2. 84% of patients had an EF less than
20%, 20.8% had had a previous sternotomy, and 54.2% had moderate or severely reduced RVEF.
Overall sample demographic and preoperative health variables, as well as the breakdown between
frail vs non-frail patient characteristics based on cutoff scores of 6-MTW <200m and SPPB ≤ 7/12,
are in included in Table 2.
When 6-MWT < 200m was used to determine frailty, the only significant difference between
frail and non-frail groups was the percentage of those with diabetes (DM). A significantly larger
percent of frail patients had DM (62.5%) than non-frail patients (41.1%) (p=0.019). When SPPB ≤
7/12 was used to determine frailty, the only significant difference between the frail and non-frail
groups was in NYHF classification/AHA stage. 91.3% percent of frail patients were class IVd, with
the remaining 8.7% in classes IIIc and IIId, while 75.8% of non-frail patients were classified as IVd
and 24.3% were in class IIIc or IIId (p=0.035).
Outcomes and 6-MWT <200m
Frailty defined by 6-MWT < 200 meters was associated with a statistically significant
increase in 1-year mortality, with 31.3% mortality at one year for frail patients and 13.2% for non20

frail patients (p=0.021). Inpatient mortality was not significantly different between frail and non-frail
groups (10.9% vs 8.9%, p=0.714).
Frailty defined by 6-MWT < 200 meters was associated with a statistically significant
increase in hospital LOS with a median LOS of 24 days (IQR 17.25-43 days) for frail patients and 19
days (IQR 15-26 days) for non-frail patients (p=0.021). Frail patients were found to have a median
ICU LOS of 13 days (IQR 8-21.75) while non-frail patients were found to have ICU LOS of 10 days
(IQR 7-13), although this difference did not reach statistical significance (p=0.059).
6-MWT < 200 meters was associated with increased time mechanically ventilated. Patients
with 6-MWT < 200 meters were mechanically ventilated for a median of 71.25 hours (IQR 22.63136.25h), while non-frail patients were mechanically ventilated for a median of 22.0 hours (IQR 1750.5h) (p <0.001). Frailty as defined by 6 MWT <200 meters was also associated with increased
tracheostomy placement, with 23.8% of frail patients requiring tracheostomy placement compared to
5.5% of non-frail patients (p=0.006).
6-MWT < 200 meters was also associated with increased discharges to inpatient rehab
facilities/long term care facilities as opposed to home. 47.4% of patients with preoperative 6-MWT <
200 meters were discharge to an inpatient facility, while only 11.8% of non-frail patients were
(p<0.001).
30- and 90-day readmissions were not statistically significant between frail and non-frail
groups, when 6-MWT < 200 meters determined frailty. 25% of frail patients were readmitted within
30 days and 17.6% of non-frail patients were readmitted with 30 days of discharge after implantation
(p= 0.355). 41.1% of frail patients, versus 41.2% of non-frail patients, were readmitted within 90
days of discharge after implant (p=0.991).
Only 12 patients had both pre and post KCCQ-12 assessments documented, and only 19 had
both pre- and post-EQ-5D-3L assessments documented. Of those with EQ-5D-3L scores
documented, 8 were considered frail and 11 were not. Of those with KCCQ-12 documented, 6 were
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frail based on 6MTW <200 m, and 6 were non-frail. There was no significant change in preoperative
and postoperative QOL scores between frail and non-frail groups. For the EQ-5D-3L assessment,
mean increase in score was 4.88 pts for frail patients and 3.82 points for non-frail patients (p=0.439).
For the KCCQ-12 assessment, mean increase in score was 17.67 point for frail patients and 11.6
points for non-frail patients (p= 0.206).
Outcomes and SPPB score ≤ 7/12
Frailty as defined by SPPB score of 7/12 or less was associated with a statistically significant
increase in 1-year mortality, with 33.3% mortality at one year for frail patients and 15.6% for nonfrail patients (p=0.030). Inpatient mortality was not significantly different between frail and non-frail
groups (13.0% vs 9.1%, p=0.546).
Frailty as defined by SPPB score ≤ 7/12 was associated with a statistically significant
increase in hospital LOS, with a median LOS of 31 days (IQR 21-45 days) for frail patients and 18.5
days (IQR 15-26 days) for non-frail patients (p<0.001). With this measure, frailty was also associated
with a statistically significant increase in ICU LOS. Median ICU LOS was 15 days (IQR 11-34 days)
for frail patients and 9.5 days (IQR 7-13.75 days) for non-frail patients (p<0.001).
SPPB score ≤ 7/12 was associated with increased time mechanically ventilated. Frail patients
with SPPB score ≤ 7/12 were mechanically ventilated for a median of 81 hours (IQR 23-308h), while
non-frail patients were mechanically ventilated for a median of 22.75 hours (IQR 18.5-60.63h) (p
<0.001). SPPB score ≤ 7/12 was also associated with increased tracheostomy placement, with 31.1%
of frail patients requiring tracheostomy placement compared to 4.6% of non-frail patients (p<0.001).
SPPB score of 7/12 or less was associated with increased discharges to inpatient rehab
facilities/long term care facilities as opposed to home. 55.0% of patients with SPPB score ≤ 7/12
were discharged to an inpatient facility, while 16.7% of non-frail patients were (p<0.001).
30- and 90-day readmissions were not statistically significant between frail and non-frail
groups, when SPPB score ≤ 7/12 was the cutoff for frailty. 20% of frail patients were readmitted
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within 30 days and 18.6% of non-frail patients were readmitted with 30 days of discharge after
implantation (p= 0.886). 40.0% of frail patients versus 37.3% of non-frail patients were readmitted
within 90 days of discharge after implantation (p=0.785).
There was also no significant change in preoperative and postoperative QOL scores between
frail and non-frail groups, although there was a significant amount of data missing for this outcome.
Of patients with documented SPPB scores, only 7 patients had both pre and post KCCQ-12
assessments documented, and only 13 had both pre- and post-EQ-5D-3L assessments documented.
Of those with EQ-5D-3L scores documented, 6 were considered frail and 7 were not. Of those with
KCCQ-12 documented, 5 were frail based on SPPB score, and 2 were not frail. For the EQ-5D-3L
assessment, mean increase in score was 4.80 pts for frail patients versus 4.1 points for non-frail
patients (p=0.715). For the KCCQ-12 assessment, mean increase in score was 15.8 point for frail
patients and 11.0 points for non-frail patients (p= 0.371).
Outcomes results for frail and non-frail groups according to each frailty measure cutoff are
summarized in Table 3.
Comparison of pre- and post-operative 6-MWT
Ability to walk ≥ 200 meters during preoperative 6-MWT was not significantly associated
with the same ability after LVAD implantation (p=0.572). Of the 42 patients who could walk 200
meters or more preoperatively, 26 (61.9%) could do so postoperatively, while 16 (38.1%) could not.
Of the 40 patients who walked less than 200 meters preoperatively, 28 (70.0%) still did not walk over
200 meters after LVAD implantation, while 12 (30.0%) now could.
Logistic Regression Models
In modeling tracheotomy, SPPB score ≤ 7 was the only significant variable in the model;
those with frailty defined by SPPB score ≤ 7 were 9 times more likely to have a trach compared to
those with non-frailty (OR = 9.4, p=.01). In modeling predictors of hours mechanically ventilated,
SPPB score ≤ 7 was also the only significant variable; those with frailty defined by SPPB score ≤ 7
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were 7.5 times more likely to be in the upper quartile (>101 hours) of those mechanically vented (OR
7.5; P= 0.04).
In modeling discharge to another facility rather than home, SPPB ≤ 7 (OR = 7.5, p=.006),
older age (OR= 1.1, p=.002) and female sex (OR = 7.8, p =.019) were significant predictors. For
logistic regressions modeling hospital and ICU LOS, both SPPB score ≤ 7 (hospital: OR 6.5, p=
0.007; ICU: OR 4.7; p=0.023) and age (hospital: OR 1.1, p=0.021; ICU: OR 1.1, p=0.029) were
predictors in these models. After adjusting for age, gender, BMI, and comorbid conditions, no
variable was a significant predictor of 1-year mortality, including SPPB score.
In no model was 6-MWT found to be a statistically significant predictor of the outcome
evaluated after adjustment for age, gender, BMI, previous sternotomy, preoperative reduction in
RVEF, and other comorbidities,.
Discussion
For this study, preoperative frailty was independently determined using both 6-MWT of 200
meters or less and SPPB score of 7/12 or less. In the same sample, more patients were considered
frail using 6-MWT < 200 meters than SPPB score ≤ 7/12, which may indicate that SPPB ≤ 7/12
provides a stricter cutoff point. The prevalence of frailty as determined by either of this study’s
measures falls within the range found in other studies of patients undergoing LVAD implantation.
Frailty prevalence was as low as 22.2% when hand grip strength was used to determine frailty
(Chung et al., 2014) and ranged from 47.5 to 75% in studies using Fried score of ≤ 3/5 to determine
frailty (Jha et al., 2017; Reeves et al., 2016).
Overall, frailty was associated with worse postoperative outcomes for patients who were
identified as being frail preoperatively. Based on the determination of frailty as 6-MWT < 200
meters, patients who were identified as frail had a significant increase in 1-year mortality, hospital
LOS, hours mechanically ventilated, tracheostomy placement, and discharge to inpatient facility
rather than home. Those who were identified as frail using SPPB score of 7/12 or less also had a
24

significant increase in these negative outcomes, as well as longer ICU LOS. There was no significant
difference in inpatient mortality, 30- or 90-day readmission rate, or change in pre-/post-operative
QOL scores between frail and non-frail groups for both frailty measures.
Frailty was associated with increased 1-year mortality for both measures of frailty and was
similar between the two measures. 1-year mortality for frail and non-frail groups was 31.3% vs
13.2% when frailty was defined as 6 MTW <200 meters (p=0.021) and 33.3% vs 15.6% when frailty
was defined as SPPB score ≤ 7/12 (p=0.030). When either measure was used to determine frailty, 1year mortality was more than doubled for frail patients. This finding further confirms the results of
other studies which used different measures (such as Fried score) to compare frailty and post-implant
mortality, as the majority (4/6) found preoperative frailty to be associated with a statistically
significant increase in mortality at 6 months or 1 year (Chung et al. 2014; Cooper et al., 2017;
Dunlay et al., 2014; Stein et al., 2019). Although frailty was associated with increased 1-year
mortality, inpatient mortality was not significantly different between frail and non-frail groups in this
study, regardless of the measure used to determine frailty. This finding is similar to those of previous
studies, as none found a statistically significant difference in inpatient mortality between frail and
non-frail patients after LVAD implantation (Cooper et al., 2017; Herberton et al., 2016; Joseph et al.,
2017; Manghelli et al., 2014; & Uzun et al., 2019).
Frailty was also associated with a statistically significant increase in LOS when defined by
either measurement. When a cutoff of 6-MWT <200 meters was used, median hospital LOS was 24
days for frail patients and 19 days for non-frail patients (p=0.021). An even larger difference was
noted when a when cutoff of SPPB ≤ 7/12 was used: median hospital LOS was 31 days for frail
patients and 18.5 days for non-frail patients (p<0.001). Currently, 7/9 studies have found that patients
who were frail preoperatively had longer postoperative LOS as discussed in the literature review;
however, only three of these reached statistical significance (Jha et al., 2017; Joseph et al., 2017; &
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Stein et al., 2019). The results of this study, therefore, provide further confirmation that preoperative
frailty is indeed associated with increased hospital LOS.
Frailty as defined by SPPB ≤ 7/12 was also associated with a statistically significant increase
in ICU LOS, with a median ICU LOS of 15 days for frail patients and 9.5 days for non-frail patients
(p<0.001). Patients determined to be frail by 6-MWT <200m also had a trend to toward increased
ICU LOS: median ICU LOS for frail patients was 13 days and 10 days for non-frail patients using
this measure, although this difference did not reach statistical significance (p=0.059). These finding
agree with those the only current study assessing ICU LOS (Jha et al., 2017) who found that ICU
LOS was significantly longer (12 vs 6 days) for frail patients.
Patients who were designated as frail by either measure also had a statistically significant
increase in time mechanically ventilated. Those with 6-MWT <200m were mechanically ventilated
for a median of 71.25 hours, compared to a median of 22.0 hours for non-frail patients (p <0.001).
Those with SPPB score ≤ 7/12 were mechanically ventilated for a median of 81 hours, while nonfrail patients were mechanically ventilated for a median of 22.75 hours (p <0.001). This is notable, as
the median time mechanically ventilated for non-frail patients by either measure was less than one
day, whereas those who were frail spent closer to 3 days mechanically ventilated after LVAD
implantation and were much more likely to need prolonged mechanical ventilation. This difference is
especially pronounced when SPPB ≤ 7/12 was used to determine frailty, as 25% of frail patients
according to this measure were mechanically ventilated over 308 hours, which is longer than 12 days.
Time mechanically ventilated postoperatively has been compared in three previous studies,
all of which found that found that patients who were frail spent a median of 24-68 hours longer on
the ventilator than non-frail patients after LVAD implantation. Two of these studies reached
statistical significance (Joseph et al., 2017 & Mangelli et al., 2014), while the third did not (Jha et al.,
2017). As these studies had relatively small sample sizes (n=40-75), the result of this study help to
affirm their findings and increase the power of results. As increased time mechanically ventilated is
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associated with increased risk for complications like delirium, muscle weakness, pressure injuries,
ventilator associated pneumonia, sepsis, and increased mortality after cardiac surgery (Loss et al.,
2015; Papathanasiou et al., 2019), its association with frailty is certainly important.
Tracheostomy placement was also significantly higher in patients who were determined to be
frail preoperatively by either measure, although the difference was greater when SPPB was used to
determine frailty. When frailty was defined as 6-MTW <200 meters, 23.8% of frail patients required
tracheostomy placement, compared to 5.5% of non-frail patients (p=0.006). When frailty was defined
as SPPB score of 7/12 or less, 31.1% of frail patients required tracheostomy placement compared to
4.6% of non-frail patients (p<0.001). This difference is certainly notable as approximately 1 in 20
non-frail patients required a trach, whereas almost 1 in 3 frail patients did.
This study was the first to assess the association between preoperative frailty and
postoperative tracheostomy placement after LVAD implantation, and both clinically and statistically
significant results were found. While tracheostomy placement facilitates ventilator weaning, reduces
the need for heavy sedation, and allows for enhanced mobility for those requiring prolonged
mechanical ventilation (Devarajan et al., 2012; Troullitt et al., 2009), its placement has also been
associated with patient discomfort, untoward effects on speech and swallowing abilities, and
decreased long term quality of life and body image perception (Bach 1993; Gilony 2005; Vargas et
al., 2018). As frail patient have much higher likelihood of requiring tracheostomy postoperatively,
this is an important potential outcome to discuss with patient as they undergo consideration for
LVAD implantation.
Frailty, when defined by either of this study’s measures, was also associated with a
statistically significant increase in discharges to acute rehab/long term care facilities, as opposed to
home. When 6-MWT <200 meters determined frailty, 47.4% of frail patients were discharged to an
inpatient facility compared to 11.8% of non-frail patients (p<0.001). When SPPB score ≤ 7/12 was
used to determine frailty, 55.0% of patients deemed frail were discharged to an inpatient facility,
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compared to 16.7% of non-frail patients (p<0.001). Currently only one other study (Dunlay et. al.,
2016), which found a non-statistically significant increase in the likelihood of discharge to rehab
facility rather than home, had evaluated this outcome. This study further supports the association
between preoperative frailty and increased likelihood of discharge to an inpatient facility rather than
home after LVAD implantation.
It may seem intuitive that frail patients will need more rehabilitation services postoperatively
than their non-frail counterparts, which has been the case after other types of cardiac surgery
(Bergquist et al., 2018). Current research, however, was unclear as to whether frail patients would
have the same needs after a LVAD implantation, as this device is designed to improve heart failure
symptoms and could potentially reverse frailty. This study demonstrates that patients who are frail
preoperatively will likely require more intense rehab services postoperatively and are less likely to be
discharged home than those who are not frail. Although this is not necessarily a bad thing, it is
important to inform patients of the potential need for inpatient rehab services in order to shape their
understanding of the recovery process after LVAD implantation. Such insight may also help to
facilitate earlier discharge planning.
In this study, 30- and 90-day readmissions were not significantly different between frail and
non-frail groups in this study, regardless of which measure was used to determine frailty. This
finding is similar to the other two studies which have assessed rehospitalization rates post- LVAD
implantation, both of which found readmission rates to be similar between frail and non-frail patients
(Cooper et al., 2017 & Dunlay et al., 2014). Reasons for readmission were also similar between
groups with GI bleed, HF exacerbation symptoms, altered mental status, and LVAD alarms and
complications being the most prevalent.
There was also no significant change in preoperative and postoperative QOL scores between
frail and non-frail groups, regardless of the measure used to determine frailty; although, there was a
significant amount of data missing for this outcome which may have influenced the fidelity and/or
28

power of results. Interestingly, although not a statistically significant finding, mean increase in QOL
scores was higher for patients who were frail preoperatively. This may indicate that receipt of an
LVAD stands to improve QOL more for patient who are frail. Although other outcomes may be
worse for patients who are frail pre-implant compared to their non-frail counterparts, they still may
experience better quality of life after implantation than they did before.
Only one other previous study has assessed the influence of frailty on QOL after LVAD
implantation. Reeves and colleagues (2016) found that patients who were frail preoperatively had
significantly lower QOL scores than non-frail patients. They, however, assessed only postoperative
surveys, whereas in this study, change in pre-and post-surveys were compared. As QOL is
subjective, an individual’s change in QOL over time may more accurately reflect the influence of
frailty on this outcome after implantation. As this study was missing a considerable amount of data,
further research is still certainly needed to investigate this topic.
While both measures of frailty demonstrated statistically significant differences between frail
and non-frail patients in tracheostomy placement, discharge to inpatient facility rather than home, 1year mortality, hospital LOS, and hours mechanically ventilated in bivariate statistical analyses,
SPPB score ≤ 7/12 was the only frailty measure predictive of negative outcomes in logistic
regression models. After adjustments were made for age, gender, BMI, previous sternotomy,
preoperative reduction in RVEF, and other comorbid conditions, patients determined to be frail by
SPPB score ≤ 7/12, were 9.4 times more likely to have a tracheostomy placed (p=0.01) and 7.5 times
more likely mechanically ventilated for a prolonged period of time (>101 h) (p= 0.04). Patients with
SPPB score ≤ 7/12 were 6.5 times more likely to have prolonged hospital LOS (p= 0.007), 4.7 times
more likely to have prolonged ICU LOS (p=0.023) and were 7.5 times more likely to be discharged
to an inpatient facility rather than home (p=0.01). 6-MWT <200m, on the other hand, was not found
to be a significant predictor of any outcomes in the models, which points to the superiority of SPPB ≤
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7/12 in predicting negative outcomes, even when adjustment are made for age, gender, BMI and
comorbidities.
Interestingly, few variables other than SPPB score were significant predictors of negative
outcomes. SPPB ≤ 7/12 was the only significant predictor of time mechanically ventilated and
tracheostomy placement. There only one instance where another variable was a stronger predictor of
an outcome than SPPB: female sex had a higher OR (7.8) than SPPB ≤ 7/12 (OR 7.5) for predicting
discharge to inpatient facility. Older age was also a predictor of increased hospital LOS, ICU LOS,
and discharge to an inpatient facility rather than home, although the odds ratio was 1.1 for each of
these outcomes, which is much lower than those associated with SPPB score ≤ 7/12. Overall, the
logistic regression models demonstrated that frailty defined by SPPB ≤ 7/12 consistently predicted
negative outcomes better than any other baseline demographic or health variable
The original plan for this project included analysis of postoperative 6-MWT in the logistic
regression models to assess whether postoperative frailty was a stronger predictor of outcomes (see
objective 5). This analysis was ultimately foregone as the timing of documentation of postoperative
6-MWTs was quite variable, ranging from inpatient stay after implantation to anytime during the first
postoperative year, and there was concerns that this would affect the fidelity the analysis of outcomes
primarily experienced inpatient. Results of 6-MWT were still compared pre- and post-operatively.
In this analysis, ability to walk ≥200 meters on 6-MWT was not significantly associated with
the same ability after LVAD implantation (p=0.572). Of the 42 patients who could walk 200 meters
or more preop, 26 (61.9%) could do so postop, while 16 (38.1%) could not. Of the 40 patients who
walked less than 200 meters preop, 28 (70.0%) still did not walk over 200 meters after LVAD
implantation, while 12 (30.0%) now could. So, while 6-MWT improved for 30% of frail patients
(suggesting that frailty may be reversible), it also worsened for 38.1% of non-frail patients. However,
as 6-MWT were recorded at differing times within the first postoperative year, results may have been
influenced by this variation. More prospective research is needed to look at scores at different time
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interval, during inpatient postop, at 6 months, and at 1 year, for example, to determine if/how scores
change and then relate scores to postoperative outcomes.
Impact on site and next steps
This project had little impact on the site as it was being conducted due to its design as a
mostly retrospective chart review. Findings from the data collection phase did reveal that there was a
lack of consistency in documenting pre- and postoperative QOL assessments and in the timing of
when postoperative 6-MWT are conducted. This may be due to several reasons including current lack
of priority placed on QOL and postoperative 6-MWT assessment or lack of staff/time to complete
these assessments. A next step in furthering this research project would be to continue this project
prospectively, with research personnel helping to collect data for QOL assessments and postoperative 6-MWTs prospectively to ensure consistent collection and documentation of this data. The
association between preoperative frailty and change in QOL after implantation could then be better
analyzed. 6-MWTs consistently collected in the postoperative period before discharge as well as at
one year could be used to assess change in frailty after surgery as well as determine whether
postoperative frailty is a stronger predictor of negative outcomes than preoperative frailty.
The results of this project will be disseminated to stakeholders including the LVAD
coordinating team, physical therapists, and cardiovascular surgeons who care for patients who
undergo LVAD implantation at UK hospital as next step for this project.
Implications
In line with the Iowa Model (Titler, 2001), results of this research can be used to inform
evidence-based practice change. LVADs are increasingly being implanted in patients with heart
failure, especially those who are not candidates for transplant due to presence of concomitant
comorbidities or age. These patients are often frail preoperatively. As frailty is associated with worse
postoperative outcomes—specifically increased 1-year mortality, hospital and ICU LOS, hours
mechanically ventilated, need for tracheostomy placement, and discharge to inpatient facility rather
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than home—frailty assessment should not only be completed on patients prior to LVAD
implantation, but also incorporated into the LVAD candidate selection and education process. SPPB
and 6-MWT are easily conducted assessments that require little equipment and minimal training from
staff to complete. Results of these preoperative frailty assessments can be used by providers to weigh
individuals’ personal risks versus the benefit of LVAD implantation surgery when determining
candidacy. While frailty is just one factor to consider, it may serve as an important high-risk marker
to help identify patients who may least benefit from device placement or who may require more
resources, closer follow-up, and more aggressive rehabilitation postoperatively. Results of frailty
assessments can also be used to better inform patients of more personalized risks associated with this
procedure based on their personal level of frailty and the likelihood of outcomes such as longer LOS,
tracheostomy placement, and discharge to rehabilitation facility if they are identified as frail. This
will help patients make informed decision concerning whether or not to undergo device implantation
as well as shape their expectations concerning the postoperative recovery process.
While both 6-MWT <200m and SPPB ≤ 7/12 were both associated with significantly worse
outcomes for frail patients, after correcting for age, gender, BMI, previous sternotomy, RVEF, and
other comorbidities, SPPB was a significant, and much stronger predictor of negative outcomes than
6-MWT. Therefore, SPPB ≤ 7/12 is likely a better measure to use to determine frailty in this
population.
As this was the first study to compare frailty as defined by SPPB ≤ 7/12 to 6-MWT < 200
meters when assessing outcomes after LVAD implant, it may be desirable to reproduce a similar
study at other facilities to confirm the results found here. Future research comparing different
measures of frailty, such as one comparing SPPB score with Fried score or handgrip strength, is also
needed to determine which frailty measure is the best predictor of outcomes in patients undergoing
LVAD implantation.
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Additionally, there is a need for more prospective research concerning frailty and QOL after
LVAD implantation. This study had a significant amount of missing QOL data and was unable reach
statistical significance. In this study, patient who were frail preoperatively had larger, although not
statistically significant, improvements in QOL scores. This topic is certainly worth further
investigation, as frail patients may stand to experience better quality of life after implantation, despite
experiencing worse postoperative outcomes than non-frail patients. For some patients, this may be
considered the most important outcome.
Prospective studies comparing 6-MWT time or other measure of frailty (like SPPB or Fried
score) preoperatively and at consistent intervals postoperatively would also be useful in helping to
determine how frailty is modified over time after LVAD implantation and if change in frailty after
implantation is a stronger predictor of inpatient and longer-term outcomes. As postoperative 6MWTs were collected at varying points throughout the first postoperative year, such an analysis
could not be conducted for this study.
Lastly, research investigating whether targeted interventions can improve frailty in patients
with heart failure is also needed. Currently, one such study, the REHAB-HF study is in progress. The
REHAB-HF is a NIH funded, randomized controlled trial assessing whether a 12-week rehabilitation
intervention improves frailty in patients with acute decompensated heart failure (Kitzman,
NCT02196038). If frailty can be improved using such interventions, efforts could be made to
improve frailty prior to LVAD implantation in order reduce the risk of negative postoperative
outcomes associated with frailty.
Limitations
This was a single center study of 120 patients. Although, this sample is fairly sizable for a
single center study of patients who underwent LVAD implantation—a procedure performed with
limited frequency and at a limited number of institutions—there is still the potential that sample size
may have underpowered the results. As this was a single center study with a majority male,
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Caucasian sample with non-ischemic cardiomyopathy, one must be careful when generalizing these
results to other populations or at other institutions.
Additionally, this is a descriptive study with the majority of data being retrospectively
collected. As a result, temporal bias may have influenced this study. As data was collected through
retrospective chart review of documentation completed by other healthcare providers, the
completeness/accuracy of documentation could not be controlled by study personnel. As discussed
previously, postoperative 6-MWTs were documented at inconsistent intervals postoperatively, which
may have influenced the validity of the comparison between patients pre- and postoperative results.
Additionally, due to this inconsistency, postoperative 6-MWT could not be assessed as a stronger
predictor of negative outcomes than preoperative frailty in our logistic regression models.
A large amount of data was also missing for pre- and postoperative QOL assessments. In
total, only 12 patients had both pre and post KCCQ-12 assessments documented, and only 19 had
both pre- and post-EQ-5D-3L assessments documented. With such a small number of completed
assessments, results concerning frailty and QOL scores were underpowered and potentially biased,
which limits the utility of these particular results. It may also be important to note that results of QOL
scores can only be collected from patients who survive, return to clinic, and are able to complete the
papers surveys by themselves or with the assistance of a member of the healthcare team. This may
inflate post-survey scores as those who experienced more morbidity after LVAD implantation may
not be able to complete 6 month-1year follow up surveys.
Lastly, rehospitalizations at other institutions at other institutions could not be captured in
this study. However, UK is one of 2 centers in the state equipped with staff trained to care for
patients with LVADs; and, therefore, the LVAD coordinators arrange for almost all patients
requiring hospital admission to be transferred to UK hospital. Therefore, few rehospitalizations likely
went uncaptured, and uncaptured hospitalizations were unlikely to differ between frail and non-frail
groups.
34

Conclusion
Many patients with advanced heart failure who undergo LVAD implant are frail
preoperatively. The results of this project revealed that preoperative frailty, as determined by 6-MWT
<200 m or SPPB ≤ 7/12, was associated with worse postoperative outcomes. Patients determined to
be frail by these measures had significantly higher 1-year mortality, longer LOS, longer time
mechanically ventilated, increased need for tracheostomy placement, and were more likely to be
discharged to an inpatient facility rather than to home. After adjustment for age, gender, BMI,
previous sternotomy, and other comorbidities, SPPB ≤ 7/12, remained a significant predictor of these
outcomes, highlighting its likely superiority over 6-MWT in defining frailty in this population.
As frailty is associated with negative outcomes, preoperative frailty assessment can help
identify patients who many not be good candidates to benefit from LVAD placement or those who
may require more resources, closer follow-up, and more aggressive rehabilitation postoperatively.
Insights attained from frailty assessment may also be useful in informing patients of more
personalized risks associated with their level of frailty as they consider whether to undergo device
implantation.
Future research is still needed on the effects of frailty on outcomes after LVAD implant.
Reproduction of a study similar to this one at other institutions would likely be beneficial to further
confirm and increase the generalizability of the results found here. Additionally, further research is
needed to determine which frailty assessment is the best predictor of outcomes in patients undergoing
LVAD implantation, whether frailty can be reversed in heart failure patients prior to or after surgery
and how this influences outcomes, and frailty’s influence on the change in patients’ quality of life
after implantation.
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Table 1. Literature review: Effect of preoperative frailty on outcomes after LVAD implant
Citation

Design

Sample

Frailty
Measure

Level of
Evidence*

Inpatient
mortality

Chung et al.
(2014)

Prospective
Observational

n = 72
(16 frail)

Handgrip
strength

Level III

Cooper et al.
(2017)

Retrospective

n = 2469
(227 frail)

Provider
score; gait
speed

Level III

Dunlay et al.
(2014)

Prospective
Observational

n = 99
(34 frail)

Frailty deficit
index

Level III

Herberton
et al. (2016)

Retrospective

n = 100
(32 frail)

Psoas muscle
mass

Level III

Jha et al
(2017)

Retrospective

n = 40
(19 frail)

Fried Score

Level III

Joseph et al.
(2017)

Prospective
Observational

n = 75
(44 frail)

Fried Score

Level III

 NS

Manghelli et
al. (2014)

Prospective
observational

n = 45
(31 frail)

Fried score

Level III

 NS

Reeves et al.
(2016)

Prospective
Observational

n = 69
(54 frail)

Fried score

Level III

Stein et al.
(2019)

Prospective
Observational

n = 44

Fried score;
grip strength

Level III

Uzam et al.
(2019)

Prospective
Observational

n = 52
(29 frail)

Fried score

Level III

Long term
Mortality

LOS

ICU
LOS

Time Mech. Non-home Readmits
Ventilated discharge

QOL

 SS

 NS

 SS

Ø

 SS

Ø

 NS

Ø

 NS

 NS
 NS

 SS

 SS

Ø

 SS

 SS

 NS

 SS

Ø

 NS
 SS
 NS

Ø

 SS

 SS
 NS

Legend:  = Increase in outcome;  = Decrease in outcome; Ø = No change; SS = Statistically Significant; NS- Not statistically significant
*John Hopkins Levels of Evidence: Level I: Experimental study, RCT; Level II: Quasi Experimental study; Level III: Non-experimental study; Level IV: Opinion of respected authorities, practice
guidelines; Level V: Quality improvement projects and case reports (John Hopkins University, 2017)
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Table 2. Baseline health data for frail and non-frail groups for each frailty cutoff measure
Variable

Overall
% (n)

SPPB > 7
Non-frail
% (n)

SPPB ≤ 7
Frail
% (n)

P value

6 MWT ≥ 200
Non-frail
% (n)

6 MWT < 200
Frail
% (n)

P value

Age
19-39
40-59
60-79
80+

17.5 (21)
40.8 (49)
40.8 (49)
0.8 (1)

19.7 (13)
42.4 (28)
37.9 (25)
0.0 (0)

15.2 (7)
39.1 (18)
43.5 (20)
2.2 (1)

0.340

25.0 (14)
37.5 (20)
39.3 (22)
0.0 (0)

10.9 (7)
45.3 (29)
42.2 (27)
1.6 (1)

0.203

Race
White
Black

90.0 (108)
10.0 (12)

89.4 (59)
10.6 (7)

89.1 (41)
10.9 (5)

1.000

91.1 (51)
8.9 (5)

89.1 (57)
10.9 (7)

0.151

Gender
Male
Female

84.2 (101)
15.8 (19)

83.3 (55)
16.7 (11)

84.8 (39)
15.2 (7)

0.837

89.3 (50)
10.7 (6)

79.7 (51)
20.3 (13)

0.151

BMI
18.5-24.9
25-29.9
30-39.9
>40

21.7 (26)
22.5 (27)
45.0 (54)
10.8 (13)

25.8 (17)
25.8 (17)
36.4 (24)
12.1 (8)

17.4 (8)
21.7 (10)
50.0 (23)
10.9 (5)

0.281

21.4 (12)
26.8 (15)
42.9 (24)
8.9 (5)

21.9 (14)
18.8 (12)
46.9 (30)
12.5 (8)

0.488

EF
<20%
≥20%

84.0 (100)
16.0 (19)

86.2 (56)
13.8 (9)

80.4 (37)
19.6 (9)

0.421

89.1 (49)
10.9 (6)

79.7 (51)
20.3 (13)

0.163

CM type
Non-ischemic
Ischemic

50.8 (61)
49.2 (59)

51.5 (34)
48.5 (32)

47.8 (22)
52.2 (24)

0.701

55.4 (31)
44.6 (25)

46.9 (30)
53.1(34)

0.345

HF class
3c
3d
4d

5.0 (6)
14.2 (17)
80.8 (97)

7.6 (5)
16.7 (11)
75.8 (50)

2.2 (1)
6.5 (3)
91.3 (42)

0.035

5.4 (3)
19.6 (11)
75.0 (42)

4.7 (3)
9.4 (6)
85.9 (55)

0.148

Prior
sternotomy
Yes
No

20.8 (25)
79.2 (95)

22.7 (15)
77.3 (51)

19.6 (9)
80.4 (37)

0.688

19.6 (11)
80.4 (45)

21.9 (14)
78.1 (50)

0.746

DM
Yes
No

52.5 (63)
47.5 (57)

45.5 (30)
54.5 (36)

56.5 (26)
43.5 (20)

0.249

41.1 (23)
58.9 (33)

62.5 (40)
37.5 (24)

0.019

COPD
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Yes
No

29.2 (35)
70.8 (85)

31.8 (21)
68.2 (45)

23.9 (11)
76.1 (35)

0.362

28.6 (16)
71.4 (40)

29.7 (19)
70.3 (45)

0.893

HTN
Yes
No

65.0 (78)
35.0 (42)

65.2 (43)
34.8 (23)

60.9 (28)
39.1 (18)

0.644

69.6 (16)
30.4 (17)

60.9 (39)
39.1 (25)

0.319

CKD
Yes
No

44.2 (53)
55.8 (67)

43.9 (29)
56.1 (37)

39.1 (18)
60.9 (28)

0.612

46.4 (26)
53.6 (30)

42.2 (27)
57.8 (37)

0.641

Pulm HTN
Yes
No

39.2 (47)
60.8 (73)

34.8 (23)
65.2 (43)

43.4 (20)
56.5 (26)

0.356

33.9 (19)
66.1 (37)

43.8 (28)
56.3 (36)

0.272

RVEF reduction
normal
mild
mild/mod
mod
mod/severe
severe

16.1 (19)
20.3 (24)
9.3 (11)
23.7 (28)
12.7 (15)
17.8 (21)

20.3 (13)
18.8 (12)
9.4 (6)
25.0 (16)
10.9 (7)
15.6 (10)

10.9 (5)
21.7 (10)
8.7 (4)
21.7 (10)
15.2 (7)
21.7 (10)

0.277

14.5 (8)
23.6 (13)
5.5 (3)
30.9 (17)
10.9 (6)
14.5 (8)

17.5 (11)
17.5 (11)
12.7 (8)
17.5 (11)
14.3 (9)
20.6 (13)

0.711

LVAD type
HVAD
HMII
HM3

51.7 (64)
18 (15)
33.3 (40)

48.5 (32)
10.6 (7)
40.9 (27)

63.0 (29)
8.7 (4)
28.3 (13)

0.340

50.0 (28)
14.3 (8)
35.7 (20)

53.1 (34)
15.6 (10)
31.3 (20)

0.873

INTERMACS
1
2
3
4

5.9 (18)
41.6 (47)
39.8 (45)
2.7 (3)

7.9 (5)
49.2 (27)
47.6 (30)
1.6 (1)

23.8 (10)
40.5 (17)
31.0 (13)
4.8 (2)

0.080

7.5 (4)
45.3 (24)
45.3 (24)
1.9 (1)

23.3 (14)
38.3 (23)
35.0 (21)
3.3 (2)

0.123
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Table 3. Outcomes of frail and non-frail groups for each cutoff measure
Outcome

SPPB > 7
Non-frail
(n=66)
15.6% (10)

P value

1-year mortality

SPPB ≤ 7
Frail
(n=46)
33.3% (15)

6 MWT ≥ 200
Non-frail
(n=56)
13.2% (7)

P value

0.030

6 MWT < 200
Frail
(n=64)
31.3% (20)

Inpatient mortality

13.0% (6)

9.1% (6)

0.546

10.9% (7)

9.8% (5)

0.714

Hospital LOS (days)*

31 [21,45]

18.5 [15,26]

<0.001

24 [17.25,43]

19 [15,26)

0.012

ICU LOS (days)*

15 [11,34]

9.5 [7,13.75]

<0.001

13 [8,21.75]

10 [7,13]

0.059

Hours Mechanically
ventilated*

81 [23,308]

22.75 [18.5,60.63]

<0.001

71.25 [22.63, 136.25]

22 [17,50.5]

<0.001

Tracheostomy placement

31.1% (14)

4.6% (3)

<0.001

23.8% (15)

5.5% (3)

0.006

Discharge to inpatient
facility

55.0% (22)

16.7% (10)

<0.001

47.4% (27)

11.8% (6)

<0.001

30-day readmission

20.0% (8)

18.6% (11)

0.886

25.0% (14)

17.6% (9)

0.355

90-day readmission

40.0% (16)

37.3% (22)

0.785

41.1% (23)

41.2% (21)

0.991

Mean change in EQ-5D-3L
score (points)

+4.8

+4.1

0.751

+4.88

+3.83

0.439

Mean change in KCCQ-12
scores (points)

+15.8

+11.0

0.371

+17.67

+11.6

0.206

*LOS, ICU LOS, and hours mechanically ventilated are expressed as median [interquartile range]
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0.021

Appendix A: Iowa Model Flow Chart

Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015. For permission to use or
reproduce, please contact the University of Iowa Hospitals and Clinics at 319-384-9098. (Iowa Model Collaborative, 2017)
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Appendix B: Short Physical Performance Battery

Note: The SPPB was developed by the National Institute on Aging in the United States and is available
for use without permission or royalty fees.
Image retrieved from Bogin et al., 2014.
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Appendix C: Study Variables with Measures
Variable

Measure
Preoperative Frailty measures
Frailty determined by six-minute
<200 m walked during 6 MWT (Y/N)
walk time (6-MWT)
Frailty determined by short physical
SPPB score ≤7/12
performance battery (SPPB) score
(Y/N)
Postoperative Outcomes Measures
Postoperative hospital length of stay
Days
(LOS)
Postoperative ICU LOS
Days
Time on mechanical ventilation
Hours
Placement of tracheostomy
Documented tracheostomy operative note (Y/N)
Discharge disposition

Inpatient mortality

Type of location documented in discharge note
(i.e. home, rehabilitation facility, long term care
facility)
Documented time of death during operative
admission (y/n)

1-year mortality

Documented death during 1st postoperative year
(y/n)

Readmission at
-30 days
-90 days

Documented hospital readmission at
- 30 days (y/n)
- 90 days (y/n)
of discharge after LVAD implantation
Numerical change in pre/postop EQ-5D-3L*
quality of life score

Change in quality of life (QOL)
scores

Numerical change in pre/postop KCCQ-12**
Score
Variable

Measure

Postoperative Frailty Measure
Postoperative frailty on 6 MTW
<200 m walked during 6-MWT (Y/N)
Demographic and Baseline Heath Measures
Age at time of implant
Years:
19-39
40-59
60-70
80+
Gender
Male/Female
Race
White
African American
Other
50

≥20%
<20%
Class IIIc, IIId, or IVd

Ejection Fraction
New York Heart Failure (NYHF)
Classification/ American Heart
Association (AHA) Stage
Body Mass Index (BMI)

Interagency Registry for
Mechanically Assisted Circulatory
Support (INTERMACS) profile score
Cardiac Index
Pre-implant reduction in right
ventricular ejection fraction (RVEF)

Comorbid presence of diabetes (DM)
Comorbid presence of hypertension
(HTN)
Comorbid presence of chronic kidney
disease (CKD)
Comorbid presence Chronic
obstructive pulmonary disease
(COPD)
Diagnosed pulmonary hypertension
Type of LVAD implanted

Ischemic vs non-ischemic
cardiomyopathy
Prior sternotomy

<18.5 k/m2
18.5-24.9 k/m2
25 – 29.9 k/m2
30-39 k/m2
>40 k/m2
INTERMACS profile 1-6

L/min/m2
Normal
Mild
Mild-Moderate
Moderate
Moderate to Severe
Severe
Documented diagnosis of DM (Y/N)
Documented diagnosis of HTN (Y/N)
Documented diagnosis of CKD (Y/N)
Documented diagnosis of COPD (Y/N)

Documented diagnosis of pulmonary HTN (Y/N)
HVAD
Heartmate II
Heartmate 3
Documentation either ischemic or non-ischemic
cardiomyopathy
Documentation of prior sternotomy (y/n)

*3-level EuroQol 5 Dimensions Questionnaire (EQ-5D-3L)
**12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
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